Orion Nutraceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Orion Nutraceuticals Stock Forecast and Price Target
The average price target for Orion Nutraceuticals's stock of 0.00 recently provided by leading analysts would represent a 100% upside from its last closing price if reached. This potential increase is based on a high estimate of 0.00 and a low estimate of 0.00. If you're considering investing in ORI stock, it's important to look at its competitors too.
0.00% Upside
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.53 | Buy/Sell | $9.50 | 11.37% |
| TLRY Stock Forecast | Tilray Brands | Outperform |
6
|
$1.84 | Buy/Sell | $2.74 | 19.57% |
| BLU Stock Forecast | BELLUS Health | - |
6
|
C$19.48 | Buy/Sell | C$0.00 | -100.00% |
| JWEL Stock Forecast | Jamieson Wellness | Outperform |
18
|
C$26.38 | Buy/Sell | C$38.40 | 34.57% |
| CRON Stock Forecast | Cronos Group | Outperform |
6
|
C$3.40 | Buy/Sell | C$3.38 | -0.88% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TSND Stock Forecast | TerrAscend | Buy |
12
|
C$2.29 | Buy/Sell | C$2.74 | 25.76% |
| GUD Stock Forecast | Knight Therapeutics | Outperform |
14
|
C$5.82 | Buy/Sell | C$6.48 | 20.27% |
| ACB Stock Forecast | Aurora Cannabis | Outperform |
6
|
C$10.09 | Buy/Sell | C$1.06 | -20.71% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OGI Stock Forecast | Organigram Holdings | Outperform |
5
|
C$2.68 | Buy/Sell | C$3.31 | 39.93% |
| FIRE Stock Forecast | The Supreme Cannabis Company | - |
4
|
C$0.33 | Buy/Sell | C$0.00 | -100.00% |
| CPH Stock Forecast | Cipher Pharmaceuticals | Buy |
0
|
C$8.81 | Buy/Sell | C$5.45 | -9.19% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HITI Stock Forecast | High Tide | Buy |
8
|
C$2.91 | Buy/Sell | C$5.85 | 106.19% |
| BHSC Stock Forecast | BioHarvest Sciences | - |
6
|
C$0.23 | Buy/Sell | C$0.00 | -100.00% |
| NGEN Stock Forecast | NervGen Pharma | Outperform |
4
|
C$2.06 | Buy/Sell | C$5.00 | 142.72% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ONC Stock Forecast | Oncolytics Biotech | Outperform |
0
|
C$1.43 | Buy/Sell | C$7.83 | 319.58% |
| RX Stock Forecast | BioSyent | Outperform |
16
|
C$8.70 | Buy/Sell | C$8.00 | 3.45% |
| TH Stock Forecast | Theratechnologies | Outperform |
8
|
C$1.89 | Buy/Sell | C$8.00 | 323.28% |
Orion Nutraceuticals EBIT Forecast for 2023 - 2025 - 2030
Orion Nutraceuticals's EBIT has grown in the last year, jumping from -510.00k to -530.00k – an increase of 3.92%. In the following year, the 0 analysts surveyed believe that Orion Nutraceuticals's EBIT will decrease by 3.77%, reaching -510.02k. According to professionals, by 2030, Orion Nutraceuticals's EBIT will have decreased by 2.42%, falling down to -517.17k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VLNS Stock Forecast | The Valens | - |
0
|
C$1.01 | Buy/Sell | C$2.36 | -100.00% |
| LOVE Stock Forecast | Cannara Biotech | - |
-12
|
C$0.93 | Buy/Sell | C$0.00 | -100.00% |
| HEXO Stock Forecast | HEXO | - |
4
|
C$0.88 | Buy/Sell | C$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EBM Stock Forecast | Eastwood Bio-Medical Canada | - |
-11
|
C$0.64 | Buy/Sell | C$0.00 | -100.00% |
| SOL Stock Forecast | SOL Global Investments | - |
0
|
C$0.10 | Buy/Sell | C$0.00 | -100.00% |
| DB Stock Forecast | Decibel Cannabis | Buy |
0
|
C$0.14 | Buy/Sell | C$0.50 | 185.71% |
.jpg)